ARCHIVES

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

This article is from The Cancer Letter archive.

Vol. 18 No. 44 | November 13, 1992

Download PDF Visit The Full Archive

Related Articles

NCAB Discussion Of Working Group Report

February 28, 2003

NCAB Members Urge More Action In Support Of NCI.

December 15, 2006

Study Suggests Biomarker For Resistance to Tamoxifen

March 25, 2011

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

ACS Approves New Workplaces Intervention Cancer Control Program

April 17, 1992

In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit

December 18, 2009